Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease
Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease have?
Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has 3 citations in the OpenAlex counts ScholarIQ stores.
When was Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease published?
Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has 2025 year in the ScholarIQ index.
What is the open-access status of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?
Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease has closed oa status in the ScholarIQ index.
What is the DOI of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?
The DOI for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.
What is the PMID of Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?
The PMID for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.
What is the OpenAlex record for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease?
The OpenAlex for Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease is on the source record.